Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 7, 2022; 28(33): 4875-4889
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4875
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4875
Table 1 Characteristics of the study population
Variable | Total (n = 40) | Group | P value | |
LM-PF (n = 20) | POEM (n = 20) | |||
Male, n (%) | 26 (65) | 14 (70.0) | 12 (60.0) | 0.507 |
Age in yr, mean ± SD | 44.55 (13.77) | 44.20 (13.21) | 44.90 (14.64) | 0.875 |
Etiology of achalasia, n (%) | 1.000 | |||
Chagas disease | 9 (22.5) | 4 (20.0) | 5 (25.0) | |
Idiopathic | 31 (77.5) | 16 (80.0) | 15 (75.0) | |
BMI in kg/m2, mean ± SD | 22.78 (4.49) | 22.79 (4.41) | 22.77 (4.70) | 0.988 |
Eckardt score, median (IQR) | 8.00 (6.25-9.00) | 8.50 (7.25-9.75) | 8.00 (6.00-9.00) | 0.478 |
Table 2 Eckardt scores
Time point | Total (n = 40), median (IQR) | Group | P value1 | |
LM-PF (n = 20), median (IQR) | POEM (n = 20), median (IQR) | |||
Baseline | 8.00 (6.25-9.00) | 8.50 (7.25-9.75) | 8.00 (6.00-9.00) | 0.478 |
1 mo | 0.00 (0.00-1.00) | 0.00 (0.00-1.00) | 1.00 (0.00-1.00) | 0.192 |
6 mo | 0.00 (0.00-1.75) | 0.00 (0.00-1.00) | 0.50 (0.00-2.00) | 0.242 |
12 mo | 0.00 (0.00-1.75) | 0.00 (0.00-1.00) | 0.50 (0.00-2.00) | 0.242 |
Table 3 Treatment success
Time point | Total (n = 40), n (%) | Group | P value1 | |
LM-PF (n = 20), n (%) | POEM (n = 20), n (%) | |||
1 mo | 40 (100.0) | 20 (100.0) | 20 (100.0) | - |
6 mo | 38 (95.0) | 20 (100.0) | 18 (90.0) | 0.487 |
12 mo | 39 (97.50) | 20 (100.0) | 19 (95.0) | 1.000 |
Table 4 Reflux esophagitis
Time point | n (%) of Total | Group | P value1 | |
LM-PF, n (%) of Total | POEM, n (%) of Total | |||
Baseline | 1 (2.5) of 40 | 0 (0.0) of 20 | 1 (5.0) of 20 | 1.000 |
1 mo | 5 (13.5) of 37 | 0 (0.0) of 20 | 5 (29.4) of 17 | 0.014 |
6 mo | 11 (32.4) of 34 | 1 (5.6) of 18 | 10 (62.5) of 16 | < 0.001 |
12 mo | 13 (37.1) of 35 | 2 (11.1) of 18 | 11 (64.6) of 17 | 0.002 |
Table 5 Height of the barium column in cm
Variable | Total (n = 40) | Group | |
LM-PF (n = 20) | POEM (n = 20) | ||
Height at 1 min | |||
Baseline | 17.48 (8.11) | 16.97 (6.70) | 17.99 (9.46) |
1 mo | 9.90 (5.88) | 11.39 (4.18) | 8.42 (6.99) |
6 mo | 8.91 (4.49) | 9.61 (3.72) | 8.22 (5.15) |
12 mo | 10.35 (3.38) | 10.98 (2.73) | 9.73 (3.90) |
Height at 5 min | |||
Baseline | 15.31 (8.13) | 14.92 (7.06) | 15.69 (9.24) |
1 mo | 5.53 (5.41) | 6.30 (4.84) | 4.75 (5.95) |
6 mo | 5.69 (5.14) | 5.99 (4.56) | 5.39 (5.77) |
12 mo | 8.31 (4.96) | 8.66 (4.92) | 7.97 (5.10) |
Table 6 Esophageal manometry results of lower esophageal sphincter pressure in mmHg
Variable | Time point | Total (n = 40) | Group | |
LM-PF (n = 20) | POEM (n = 20) | |||
Maximal expiratory pressure | Baseline | 25.98 (10.42) | 24.53 (9.90) | 27.43 (10.98) |
6 mo | 10.44 (5.86) | 9.93 (5.45) | 10.94 (6.34) | |
12 mo | 10.11 (5.09) | 9.34 (4.19) | 10.87 (5.85) |
Table 7 Adverse events, length of hospital stay, anesthesia time, and procedure time
Variable | Total (n = 40) | Group | P value | |
LM-PF (n = 20) | POEM (n = 20) | |||
Adverse events, n (%) | 4 (10.0) | 1 (5.0) | 3 (15.0) | 0.605a |
Length of hospital stay in d | 3.68 (2.42) | 3.95 (3.36) | 3.40 (0.75) | 0.483b |
Anesthesia time in min | 240.88 (79.46) | 296.75 (56.13) | 185.00 (56.89) | < 0.001b |
Procedure time in min | 157.23 (74.81) | 218.75 (50.88) | 95.70 (30.47) | < 0.001b |
Table 8 Quality of life
SF-36 domain | Baseline score | P value | Score at 12 mo | P value | ||
LM-PF (n = 20), median (IQR) | POEM (n = 20), median (IQR) | LM-PF (n = 20), median (IQR) | POEM (n = 20), median (IQR) | |||
Physical functioning | 95.00 (70.0-100.0) | 77.50 (62.25-95.0) | 0.165 | 100.0 (90.0-100.0) | 92.50 (66.25-100.0) | 0.183 |
Role-physical | 100.0 (56.25-100.0) | 25.0 (0.00-68.75) | 0.012 | 100.0 (100.0-100.0) | 100.0 (56.25-100.0) | 0.445 |
Role-emotional | 100.0 (33.30-100.0) | 33.30 (0.00-66.70) | 0.021 | 100.0 (66.70-100.0) | 100.0 (41.65-100.0) | 0.640 |
Vitality | 67.5 (46.25-88.75) | 52.50 (36.25-65.00) | 0.052 | 85.0 (56.25-100.0) | 80.0 (56.25-90.0) | 0.341 |
Mental health | 74.0 (54.0-95.0) | 58.0 (44.0-75.0) | 0.030 | 94.0 (69.0-100.0) | 80.0 (57.0-91.0) | 0.174 |
Social functioning | 81.25 (62.50-100.0) | 56.25 (37.50-71.88) | 0.006 | 100.0 (78.13-100.0) | 93.75 (40.63-100.0) | 0.174 |
Bodily pain | 73.75 (49.38-97.50) | 62.50 (45.0-79.38) | 0.201 | 90.0 (78.13-100.0) | 80.0 (55.0-97.50) | 0.142 |
General health | 50.0 (31.25-83.75) | 55.0 (41.25-65.0) | 0.698 | 82.50 (61.25-100.0) | 67.50 (52.50-100.0) | 0.445 |
- Citation: de Moura ETH, Jukemura J, Ribeiro IB, Farias GFA, de Almeida Delgado AA, Coutinho LMA, de Moura DTH, Aissar Sallum RA, Nasi A, Sánchez-Luna SA, Sakai P, de Moura EGH. Peroral endoscopic myotomy vs laparoscopic myotomy and partial fundoplication for esophageal achalasia: A single-center randomized controlled trial. World J Gastroenterol 2022; 28(33): 4875-4889
- URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4875.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i33.4875